• Land: Schweiz

Nachricht vom 08.03.2021 | 10:00

Fifteenth Annual BIO-Europe Spring Digital to bring together 2,500 life science leaders

DGAP-News: EBD Group / Key word(s): Conference
08.03.2021 / 10:00
The issuer is solely responsible for the content of this announcement.

Fifteenth Annual BIO-Europe Spring Digital to bring together 2,500 life science leaders

Munich, Germany - March 08, 2021: The 15th annual BIO-Europe Spring global life sciences partnering event will be held March 22-25, 2021 in a fully digital format. Partnering is in full swing, on its third week, and on-demand company presentations, program sessions, and sponsor as well as showcase company content are already available allowing engagement without interrupting busy partnering schedules during the main event week.

The opening keynote plenary discussion "In the thick of it: Navigating beyond vaccine discovery" on Monday, March 22, will feature speakers Marianne De Backer, Executive VP, Head of Strategy, Business Development & Licensing and Executive Committee Member at Bayer AG, Francesco De Rubertis, Partner at Medicxi Pharmaceuticals, Monika Vnuk, VP Business Development at Pfizer; and moderator Eleanor Malone, Editor in Chief, Commercial Insights, Informa Pharma Intelligence.

Tuesday features a live Q&A networking session with Michael Engsig, CEO at Vaccibody and Don O'Sullivan, Head of Oncology, Pharma Partnering at Roche Business.

On Wednesday, the well-established bi-annual "Day in the life of an experienced dealmaker" panel discussion will again highlight and discuss current deals with the speakers Anton Gueth, Managing Director at EVOLUTION Life Science Partners, Evonne Sepsis, Founder and Managing Director at ESC Advisors, John Hamer, Managing Partner at DCVC Bio, Genghis Lloyd-Harris, Partner at Abingworth and Jay Stamatis, VP Business Development and Acquisitions at Abbvie.

Additionally, high-level executives from pharma, biotech, and the investment sector are confirmed to participate in panels and discussions covering a wide range of topics including fostering diversity within biotech leadership, oncology, rare diseases, manufacturing in the pandemic, clinical trial developments, and AI and machine learning in healthcare.

The event is expected to bring together 2,500 executives from 1,300 life sciences companies spanning an estimated 45+ countries to engage in one-to-one partnering.

Registration and event information are available online.

Upgrade your registration:

Taking place a week before BIO-Europe Spring, Startup Springboard, March 18, will provide biopharma companies with new opportunities to engage with a pool of curated pipeline companies. Join us for a dynamic day of live virtual pitches and networking opportunities.

Are you a biotech startup? Be at the forefront and get noticed by top-tier investors and pharma execs with a 2-minute virtual pitch. View startup criteria.

Additional links and information:

Follow BIO-Europe Spring 2021 on Twitter @EBDGroup (hashtag: #BIOEuropeSpring) or LinkedIn.

About EBD Group

EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE(R), which enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today our events (BIO-Europe(R), BIO-Europe Spring(R), BioPharm America(TM), Biotech Showcase(TM), China Showcase, Digital Medicine & Medtech Showcase, ChinaBio(R) Partnering Forum, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. EBD Group is an Informa company. For more information, please visit www.ebdgroup.com.

Media Contacts:
MC Services AG
+49 89 2102280

Karina Marocco
EBD Group

08.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

Cryptology: führende europäische Holding für Krypto-Assets und Blockchain-Unternehmen

Die Cryptology Asset Group ist eine börsennotierte Beteiligungsgesellschaft mit Fokus auf Krypto-Assets und blockchainbasierte Geschäftsmodelle. Dafür steht der Crypotology ein breites Netzwerk zur Verfügung, u.a. Christian Angermayer und Mike Novogratz, zwei der weltweit prominentesten Persönlichkeiten im Kryptogeschäft, die gleichzeitig auch zu den Gründern und Hauptgesellschaftern des Unternehmens zählen. Wir haben mit dem CEO der Gesellschaft, Patrick Lowry, über die Perspektiven für Krypto-Assets und die Entwicklung der Cryptology Asset Group gesprochen.

News im Fokus

Zalando SE: Zalando startet Aktienrückkaufprogramm für Aktienoptionsprogramme

20. Januar 2022, 21:24

Aktueller Webcast

home24 SE

Trading Update FY 2021

25. Januar 2022

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von Montega AG): Kaufen

21. Januar 2022